Ciprofloxacin resistanceamong community-derived methicillin-resistant Staphylococcus aureus (MRSA) strains.
Southeast Asian J Trop Med Public Health
;
1999 Dec; 30(4): 779-80
Article
in English
| IMSEAR
| ID: sea-36277
ABSTRACT
Methicillin-resistant Staphylococcus aureus (MRSA) has been recognized as a nosocomial pathogen in Europe and North America for almost 3 decades. More recently it has emerged as a problem in long-term care facilities. However, It has been less frequently considered a pathogen in community-acquired infections, where it is most often seen in intravenous drug users. Consequently there has been very few studies, particularly in Bangladesh, documenting incidence of ciprofloxacin-resistance among MRSA in community patients. We tested clinical isolates from outdoor patients for ciprofloxacin resistance among MRSA strains, using in vitro susceptibility tests by standard disk diffusion technique. Results show significantly high incidence of ciprofloxacin resistance among MRSA isolates in these patients.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Staphylococcal Infections
/
Staphylococcus aureus
/
Bangladesh
/
Humans
/
Ciprofloxacin
/
Retrospective Studies
/
Methicillin Resistance
/
Community-Acquired Infections
/
Drug Resistance, Multiple
/
Anti-Infective Agents
Type of study:
Observational study
Country/Region as subject:
Asia
Language:
English
Journal:
Southeast Asian J Trop Med Public Health
Year:
1999
Type:
Article
Similar
MEDLINE
...
LILACS
LIS